Cargando…
Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091990/ https://www.ncbi.nlm.nih.gov/pubmed/35538869 http://dx.doi.org/10.1002/ctm2.847 |
| _version_ | 1784705044886585344 |
|---|---|
| author | Liang, Naixin Bing, Zhongxing Wang, Yadong Liu, Xinyu Guo, Chao Cao, Lei Xu, Yuan Song, Yang Gao, Chao Tian, Zhenhuan Wu, Pancheng Xue, Jianchao Li, Bowen Jia, Ziqi Yang, Xiaoying Wu, Yijun Yu, Ruoying Liu, Rui Chen, Xiaoxi Ou, Qiuxiang Bao, Hua Wu, Xue Cao, Zhili Li, Ji Li, Shanqing |
| author_facet | Liang, Naixin Bing, Zhongxing Wang, Yadong Liu, Xinyu Guo, Chao Cao, Lei Xu, Yuan Song, Yang Gao, Chao Tian, Zhenhuan Wu, Pancheng Xue, Jianchao Li, Bowen Jia, Ziqi Yang, Xiaoying Wu, Yijun Yu, Ruoying Liu, Rui Chen, Xiaoxi Ou, Qiuxiang Bao, Hua Wu, Xue Cao, Zhili Li, Ji Li, Shanqing |
| author_sort | Liang, Naixin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9091990 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90919902022-05-16 Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer Liang, Naixin Bing, Zhongxing Wang, Yadong Liu, Xinyu Guo, Chao Cao, Lei Xu, Yuan Song, Yang Gao, Chao Tian, Zhenhuan Wu, Pancheng Xue, Jianchao Li, Bowen Jia, Ziqi Yang, Xiaoying Wu, Yijun Yu, Ruoying Liu, Rui Chen, Xiaoxi Ou, Qiuxiang Bao, Hua Wu, Xue Cao, Zhili Li, Ji Li, Shanqing Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2022-05-11 /pmc/articles/PMC9091990/ /pubmed/35538869 http://dx.doi.org/10.1002/ctm2.847 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Liang, Naixin Bing, Zhongxing Wang, Yadong Liu, Xinyu Guo, Chao Cao, Lei Xu, Yuan Song, Yang Gao, Chao Tian, Zhenhuan Wu, Pancheng Xue, Jianchao Li, Bowen Jia, Ziqi Yang, Xiaoying Wu, Yijun Yu, Ruoying Liu, Rui Chen, Xiaoxi Ou, Qiuxiang Bao, Hua Wu, Xue Cao, Zhili Li, Ji Li, Shanqing Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title | Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title_full | Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title_fullStr | Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title_full_unstemmed | Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title_short | Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer |
| title_sort | clinical implications of egfr‐associated mapk/erk pathway in multiple primary lung cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091990/ https://www.ncbi.nlm.nih.gov/pubmed/35538869 http://dx.doi.org/10.1002/ctm2.847 |
| work_keys_str_mv | AT liangnaixin clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT bingzhongxing clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT wangyadong clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT liuxinyu clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT guochao clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT caolei clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT xuyuan clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT songyang clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT gaochao clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT tianzhenhuan clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT wupancheng clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT xuejianchao clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT libowen clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT jiaziqi clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT yangxiaoying clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT wuyijun clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT yuruoying clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT liurui clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT chenxiaoxi clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT ouqiuxiang clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT baohua clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT wuxue clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT caozhili clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT liji clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer AT lishanqing clinicalimplicationsofegfrassociatedmapkerkpathwayinmultipleprimarylungcancer |